Atıf İçin Kopyala
Huyut Z., BAKAN N., YILDIRIM S., Alp H. H.
MEDICAL SCIENCE MONITOR BASIC RESEARCH, cilt.24, ss.47-58, 2018 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
24
-
Basım Tarihi:
2018
-
Doi Numarası:
10.12659/msmbr.908504
-
Dergi Adı:
MEDICAL SCIENCE MONITOR BASIC RESEARCH
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus
-
Sayfa Sayıları:
ss.47-58
-
Anahtar Kelimeler:
Bone Density, Dexamethasone, Osteoporosis, Phosphodiesterase 5 Inhibitors, NITRIC-OXIDE, MINERAL DENSITY, ANTIOXIDANT ACTIVITY, COENZYME Q(10), DNA-DAMAGE, STRESS, OVARIECTOMY, EXPRESSION, SUSCEPTIBILITY, METABOLISM
-
Erzincan Binali Yıldırım Üniversitesi Adresli:
Hayır
Özet
Background: The aim of this study was to evaluate the effects of the phosphodiesterase-5 (PDE-5) inhibitors, zaprinast and avanafil, on NO signalling pathway, bone mineral density (BMD), epiphyseal bone width, bone marrow angiogenesis, and parameters of oxidative stress in a rat model of glucocorticoid-induced osteoporosis (GIOP).